Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	question first answered answering member
creator	label
publisher	pref label
tabling member	label

Search

861115

	human indexable
	published
	registered interest
	answer date	16/03/2018
	date	13/03/2018
	date tabled	13/03/2018
	ddp created	13/03/2018 20:49:44
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	13/03/2018 20:58:42 16/03/2018 12:13:05
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	identifier	132264
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	16/03/2018 11:42:43
	question text	To ask the Secretary of State for Health and Social Care, when his Department plans to publish a new five year AMR Strategy, and whether that strategy will include best practice on infection prevention and control, including hand hygiene compliance.
	session	2017/19
	session number	1
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2017/19 132264
	type	WrittenParliamentaryQuestion
	uin	132264
	version	1
	written parliamentary question type	NamedDay
	answer	answer question first answered 16/03/2018 11:42:43 answering member 4067
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

714582

	human indexable
	published
	registered interest
	answer date	30/03/2017
	date	28/03/2017
	date tabled	28/03/2017
	ddp created	28/03/2017 21:26:12
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	28/03/2017 21:50:30 05/04/2017 10:32:02
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	identifier	69526
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	05/04/2017 10:00:27
	question text	To ask the Secretary of State for Health, when he expects the Global Antimicrobial Resistance Innovation Fund to be open to research applications for the repurposing of antibiotics.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 69526
	type	WrittenParliamentaryQuestion
	uin	69526
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 05/04/2017 10:00:27 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

714584

	human indexable
	published
	registered interest
	answer date	30/03/2017
	date	28/03/2017
	date tabled	28/03/2017
	ddp created	28/03/2017 21:26:15
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	28/03/2017 21:50:32 05/04/2017 10:56:01
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	identifier	69527
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	05/04/2017 10:24:11
	question text	To ask the Secretary of State for Health, when he expects the first pilots of the Global Antimicrobial Resistance Innovation Fund on reimbursement models to incentivise the development of new classes of antibiotics to begin.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 69527
	type	WrittenParliamentaryQuestion
	uin	69527
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 05/04/2017 10:24:11 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

709358

	human indexable
	published
	registered interest
	answer date	13/03/2017
	date	08/03/2017
	date tabled	08/03/2017
	ddp created	08/03/2017 22:36:41
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	08/03/2017 22:46:47 16/03/2017 16:20:31
	hansard heading	Pharmacy: Internet
	house id	1
	identifier	66981
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/03/2017 15:44:08
	question text	To ask the Secretary of State for Health, with reference to the study published by Oxford Academic on 17 February 2017 on inappropriate checks undertaken by online pharmacies, if he will discuss with the Medicines and Healthcare Products Regulatory Agency means to prevent the online sale of antibiotics and other medicines without appropriate checks.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 66981
	type	WrittenParliamentaryQuestion
	uin	66981
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 16/03/2017 15:44:08 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

705629

	human indexable
	published
	registered interest
	answer date	01/03/2017
	date	27/02/2017
	date tabled	27/02/2017
	ddp created	28/02/2017 00:41:54
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	28/02/2017 00:47:58 07/03/2017 11:10:05
	hansard heading	Pharmacy: Internet
	house id	1
	identifier	65574
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	07/03/2017 10:37:42
	question text	To ask the Secretary of State for Health, what steps his Department is taking to regulate the online sale of (a) antibiotics and (b) other medicine.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 65574
	type	WrittenParliamentaryQuestion
	uin	65574
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 07/03/2017 10:37:42 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

669006

	human indexable
	published
	registered interest
	answer date	10/01/2017
	date	06/01/2017
	date tabled	06/01/2017
	ddp created	06/01/2017 18:22:52
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	06/01/2017 18:29:32 16/01/2017 16:59:02
	hansard heading	Antibiotics: Drug Resistance
	house id	1
	identifier	58772
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/01/2017 16:27:56
	question text	To ask the Secretary of State for Health, if his Department will take steps to record on death certificates antibiotic resistant infection as the patient's cause of death.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 58772
	type	WrittenParliamentaryQuestion
	uin	58772
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 16/01/2017 16:27:56 answering member 4080
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

669007

	human indexable
	published
	registered interest
	answer date	10/01/2017
	date	06/01/2017
	date tabled	06/01/2017
	ddp created	06/01/2017 18:22:53
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	06/01/2017 18:29:33 16/01/2017 17:27:02
	hansard heading	Antibiotics: Drug Resistance
	house id	1
	identifier	58773
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/01/2017 16:55:14
	question text	To ask the Secretary of State for Health, whether all blood assay results showing infection or resistance to antibiotics go onto a national register.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 58773
	type	WrittenParliamentaryQuestion
	uin	58773
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 16/01/2017 16:55:14 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

669001

	human indexable
	published
	registered interest
	answer date	10/01/2017
	date	06/01/2017
	date tabled	06/01/2017
	ddp created	06/01/2017 18:22:48
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	06/01/2017 18:29:23 16/01/2017 17:28:09
	hansard heading	Antibiotics: Drug Resistance
	house id	1
	identifier	58778
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	16/01/2017 16:56:07
	question text	To ask the Secretary of State for Health, if his Department will take steps to set up a National Antibiotic Register for recording all hospital and community patients who have an antibiotic resistant infection.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 58778
	type	WrittenParliamentaryQuestion
	uin	58778
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 16/01/2017 16:56:07 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

536471

	human indexable
	published
	registered interest
	answer date	18/07/2016
	date	14/07/2016
	date tabled	14/07/2016
	ddp created	14/07/2016 18:52:00
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	14/07/2016 18:57:48 19/07/2016 14:18:02
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	identifier	42800
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	19/07/2016 13:46:45
	question text	To ask the Secretary of State for Health, what role he plans for the UK in discussing antimicrobial resistance at the G20 summit in September 2016.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 42800
	type	WrittenParliamentaryQuestion
	uin	42800
	version	1
	written parliamentary question type	Ordinary
	answer	answer question first answered 19/07/2016 13:46:45 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake

536279

	human indexable
	published
	registered interest
	answer date	18/07/2016
	date	13/07/2016
	date tabled	13/07/2016
	ddp created	13/07/2016 22:01:37
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp modified	14/07/2016 18:58:12 20/07/2016 14:53:02
	hansard heading	Antibiotics
	house id	1
	identifier	42714
	legislature	25259 pref label House of Commons
	parliament number	56
	question first answered	20/07/2016 14:21:20
	question text	To ask the Secretary of State for Health, what assessment he has made of (a) the effect of the National Tariff on the choice of antibiotic therapy available in hospitals and (b) the implications of the cost of such therapy for that availability.
	session	2016/17
	session number	2
	tabling member constituency	Thirsk and Malton
	tabling member printed	Kevin Hollinrake
	title	House of Commons Tabled Parliamentary Question 2016/17 42714
	type	WrittenParliamentaryQuestion
	uin	42714
	version	2
	written parliamentary question type	Ordinary
	answer	answer question first answered 20/07/2016 14:21:20 answering member 4019
	creator	4474 label Biography information for Kevin Hollinrake
	publisher	25259 pref label House of Commons
	tabling member	4474 label Biography information for Kevin Hollinrake